Construction and evaluation of a height prediction model for children with growth disorders treated with recombinant

Feng Zhu1, Anle Wu1, Lingling Chen1

  • 1Department of Child Healthcare, Wenzhou People's Hospital/Wenzhou Maternal and Child Health Care Hospital, The Third Clinical Institute Affiliated to Wenzhou Medical University, The Third Affiliated Hospital of Shanghai University, Wenzhou, 325000, Zhejiang, China.

PubMed

Insights

Machine learning models effectively predict height gain in children undergoing growth hormone therapy. These tools aid personalized treatment by analyzing clinical data for better outcomes.

Area of Science:

  • Pediatric endocrinology
  • Biostatistics
  • Machine learning in healthcare

Background:

  • Height gain in children with growth disorders on recombinant human growth hormone (rhGH) therapy exhibits significant variability.
  • Predicting treatment response is crucial for tailoring individualized therapeutic strategies.

Purpose of the Study:

  • To develop and validate a predictive model using clinical data for early height growth response assessment in children with growth disorders undergoing rhGH therapy.

Main Methods:

  • 786 children were analyzed, split into derivation (N=551) and test (N=235) cohorts.
  • Machine learning models (logistic regression, decision tree, random forest, XGBoost, LightGBM, MLP) were built and evaluated using AUROC, AUPRC, and accuracy.
  • Key input variables included chronological age, HSDS, BSDS, IGF-1, and BA-CA.

Main Results:

  • Random forest and MLP models demonstrated superior performance.
  • The random forest model achieved an AUROC of 0.9114 and AUPRC of 0.8825.
  • MLP achieved high accuracy (0.8468), precision (0.8208), specificity (0.8583), and F1 score (0.8246). Chronological age, BA-CA, HSDS, and BSDS were most influential.

Conclusions:

  • Machine learning models, particularly random forest and MLP, effectively predict height gain in children receiving rhGH therapy.
  • These models support personalized treatment strategies for growth disorders.
  • Enhancing the interpretability of high-performing models like MLP is recommended for clinical integration.
Abstract